Christopher Moore

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization

D. Ganger, D. Mahalingam, R. Salem, 2019, Cancers.

Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating the lung shunt study.

D. Ganger, R. Salem, L. Kulik, 2020, Journal of hepatology.

Evaluation and management of insomnia, muscle cramps, fatigue, and itching in cirrhotic patients

Christopher Moore, 2016, Clinical liver disease.

A Case of Drug-Induced Liver Injury Secondary to Natalizumab

H. Maddur, P. Santoiemma, Christopher Moore, 2020, Case reports in hepatology.

The Current State and Future Prospects of Chronic Hepatitis C Virus Infection Treatment

J. Levitsky, Christopher Moore, 2014, Current Infectious Disease Reports.

Liver Transplantation Following Yttrium‐90 Radioembolization: 15‐Year Experience in 207‐Patient Cohort

D. Ganger, T. Baker, D. Ladner, 2020, Hepatology.

Assessment and Management of Nutrition Status in the Hospitalized Patient With Cirrhosis

Christopher Moore, Adam C. Stein, 2018, Clinical liver disease.

Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis

M. Abecassis, D. Ganger, R. Salem, 2021, CardioVascular and Interventional Radiology.

New models to enhance the assessment of mortality risk in low model for end‐stage liver disease patients: “Objectifying” the subjective

J. Levitsky, Christopher Moore, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

New models to enhance the assessment of mortality risk in low model for end‐stage liver disease patients: “Objectifying” the subjective

J. Levitsky, Christopher Moore, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.